Literature DB >> 12388992

The obstetrician-gynecologist's role in adult immunization.

Bernard Gonik1, Nancy Fasano, Sarah Foster.   

Abstract

Vaccine-preventable diseases (VPDs) account for significant morbidities and mortalities in the United States on an annual basis. Despite generally successful childhood vaccine programs, adults remain underimmunized against a variety of common VPDs. Lack of both physician and patient awareness contribute to this deficiency. All primary care providers, including obstetrician-gynecologists, must address this need in their office practices. Clear and authoritative adult vaccine recommendations are established and easily accessible by the clinician. Pregnancy is not an absolute contraindication to vaccine administration. In fact, certain vaccines are specifically indicated during pregnancy in the interest of the mother and her unborn child. Women frequently identify gynecologists as their sole providers of care, further emphasizing the need for attention to this health maintenance activity. New vaccine initiatives, in particular those focused on early newborn infectious conditions, sexually transmitted diseases, and cancer prevention, will likely place the obstetrician-gynecologist at the forefront of this important clinical issue.

Entities:  

Mesh:

Year:  2002        PMID: 12388992     DOI: 10.1067/mob.2002.128027

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  4 in total

1.  Diagnosis and Therapy Before Assisted Reproductive Treatments. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Register Number 015-085, February 2019) - Part 1, Basic Assessment of the Woman.

Authors:  Bettina Toth; Dunja Maria Baston-Büst; Hermann M Behre; Alexandra Bielfeld; Michael Bohlmann; Kai Bühling; Ralf Dittrich; Maren Goeckenjan; Katharina Hancke; Sabine Kliesch; Frank-Michael Köhn; Jan Krüssel; Ruben Kuon; Jana Liebenthron; Frank Nawroth; Verena Nordhoff; Germar-Michael Pinggera; Nina Rogenhofer; Sabine Rudnik-Schöneborn; Hans-Christian Schuppe; Andreas Schüring; Vanadin Seifert-Klauss; Thomas Strowitzki; Frank Tüttelmann; Kilian Vomstein; Ludwig Wildt; Tewes Wischmann; Dorothea Wunder; Johannes Zschocke
Journal:  Geburtshilfe Frauenheilkd       Date:  2019-12-11       Impact factor: 2.915

2.  Patient and clinic factors associated with adolescent human papillomavirus vaccine utilization within a university-based health system.

Authors:  Amanda Dempsey; Lisa Cohn; Vanessa Dalton; Mack Ruffin
Journal:  Vaccine       Date:  2009-11-17       Impact factor: 3.641

Review 3.  Use of B-Cell-Depleting Therapy in Women of Childbearing Potential With Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder.

Authors:  Alexandra Galati; Thomas McElrath; Riley Bove
Journal:  Neurol Clin Pract       Date:  2022-04

Review 4.  Prophylaxis and treatment of pregnant women for emerging infections and bioterrorism emergencies.

Authors:  Joanne Cono; Janet D Cragan; Denise J Jamieson; Sonja A Rasmussen
Journal:  Emerg Infect Dis       Date:  2006-11       Impact factor: 6.883

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.